A bio-tech company shaping the future of marine antifouling coatings

We are the developers of Selektope - an active antifouling agent that repels barnacles from ships

This is I-Tech AB

I-Tech is a Nasdaq First North Growth Market-listed bio-technology company [TICKER:ITECH] based in  Sweden. We develop, market and sell the performance ingredient, Selektope® for use in marine antifouling coatings.

Our vision is to establish Selektope® as the leading technology to prohibit marine growth in an effective and sustainable way.

CORPORATE CONTACTS
Philip Chaabane, CEO

Philip Chaabane

CEO

philip.chaabane@i-tech.se

Magnus Henell, CFO

Magnus Henell

CFO & Head of Operations

magnus.henell@i-tech.se

Monica Kettelhoit

Monica Kettelhoit

Office Manager

monica.kettelhoit@i-tech.se

Selektope logo light

Its powerful, repellent effect on barnacles keeps the ship's hull clean

Latest news

2023

Following the news released earlier today on May 24th 2023, I-Tech’s CEO, Philip Chaabane will give a company update regarding the renewal process...
Within the context of a re-registration process in EU, an advisory panel of experts from the European chemical agency ECHA has recommended that Medetomidine...
2023-05-04 08:00 I-Tech AB (publ) Interim report Q1 2023 Regulatory MAR
I-Tech AB (publ) (ticker: ITECH) publish the interim report for the first quarter 2023 Click here on the 4th of May at 10:30 (CEST) to follow the webcast...
Latest Presentation

Finwire webcast

October 21, 2022

Quarter 3, 2022 sets a new high for revenue and earnings for a single quarter to-date.

Watch more in this presentation where I-Tech CEO. Philip Chaabane, is talking about the third financial quarter of 2022, the shipping industry´s path towards more efficient shipping and our ingredient technology Selektope.

(37 minutes, English)

 

Investor Communications

Sign up here to get the latest press releases and financial reports from I-Tech AB directly to your inbox.